Clinical Trials

Vistar Eye Center has made a commitment to our community and our field of ophthalmology to offer the latest and best technology and care to our patients.  Research is critical in any medical field, and in eye care, there are diseases such as glaucoma, diabetic eye disease, and macular degeneration for which there is not yet a cure. There are cutting-edge advances in technologies for cataracts and refractive surgeries. Our hope is to find a cure for these diseases so we can treat people earlier and offer better procedures or pharmaceutical therapy.

Benefits of being a study candidate

  • Compensation for qualified participants
  • Patients are evaluated for participation in our clinics by our doctors at no expense to them.
  • Receiving new and innovative treatment at a reduced cost of care.

To discover if you are a candidate for participation in clinical trials contact our Clinical Studies Department at 540-855-3547, or fill in the form below.

Currently Enrolling Clinical Trials

Glaukos GC-010 – iDose Travoprost in patients with Open-Angle Glaucoma or Ocular Hypertension

Category: Glaucoma
Investigator: Dr. Frank Cotter
Sub-Investigator: Tad Schoedel

This is a 36-month study comparing two models of a Travoprost intraocular implant to Timolol Maleate Ophthalmic Solution, USP, 0.5%. This study consists of a one-time randomized surgical procedure and studies medication to be taken twice daily. 

Allergan 192024-095 - Bimatoprost SR with SLT in Patients with Open-Angle Glaucoma or Ocular Hypertension

Category: Glaucoma
Investigator: Dr. Frank Cotter
Sub-Investigator: Dr. Tad Schoedel

This is a 52-week study that will evaluate the intraocular pressure-lowering effect and safety of Bimatoprost SR compared with selective laser trabeculoplasty in patients with open-angle glaucoma or ocular hypertension who are not adequately managed with topical IOP-lowering medication. There are no drops required for this study although drops may be given at the physician’s discretion. 

Lexitas/TearSolution - Lacriprep Ophthalmic Solution

Category: Cornea/Dry Eye
Investigator: Dr. Stuart Tims

The objective of this study is to evaluate the efficacy and safety of two strengths of Lacriprep™ ophthalmic solution versus placebo administered three times daily for four weeks in subjects with a diagnosis of Dry Eye associated with documented Primary Sjögren's Syndrome

Current Research Collaborations

Vistar Eye Center is proudly collaborating with Carilion Medical Center, Anesthesiology Consultants of Virginia, and Virginia Tech Carilion School of Medicine to contribute to advances in medicine right here in our community. “The Ability of Visual Evoked Potentials Obtained During Spine Surgery to Predict Postoperative Visual Changes” is an ongoing study with participant enrollment lead by Dr. Jonathan Carmouche. 

Previous Clinical Trial Involvement 

Acular Phase III for post-cataract surgery
Alcon C-08-047 Phase III Travatan Z Study in Ocular Surface Disease
Alcon C-08-049 Anecortave Acetate Injectable in treatment of Ocular Hypertension and Open-angle glaucoma
Alcon C-09-055, C-11-003 Nepafenac in prevention/treatment of ocular pain following cataract surgery 
Alcon C-10-016 ReStor +2.50 Multifocal IOL Study 
Alcon C-10-004 Durezol in treatment in pediatrics post-operatively in cataract removal
Alcon C-10-039 Safety and Extension of the Efficacy & Safety of a fixed combination of Brinzolamide 1%/Brimonidine 0.2% in a patient with Open-Angle Glaucoma and/or Ocular Hypertension
Alcon C-11-020 High Toric IOL
Alcon C-11-039 AMD +8.00 ReStor
Allergan 192024-092 Bimatoprost SR in Patients with Open-Angle Glaucoma or Ocular Hypertension
Allergan Optive for Post-LASIK
Allergan Zymar for Conjunctivitis
Bausch & Lomb Lunar Protocol 770 for glaucoma
Ista 0415081-P Xibrom for post-cataract surgery
GLAUKOS GC-008 iStent Inject in conjunction with Cataract Surgery
GLAUKOS GC-007 Suprachoroidal iStent in conjunction with Cataract Surgery